SkinHealth Systems (SKIN) Research & Development (2020 - 2026)

SkinHealth Systems (SKIN) has reported Research & Development for 7 consecutive years, with $21.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 9.05% year-over-year to $21.0 million in Q2 2026; TTM through Jun 2026 was $88.7 million, a 14.17% decrease from a year earlier, with the FY2025 full-year figure at $93.6 million, down 20.89% from the prior year.
• Research & Development was $21.0 million for Q2 2026 at SkinHealth Systems, down from $23.2 million in the prior quarter.
• Over five years, Research & Development peaked at $44.9 million in Q2 2022 and troughed at $20.9 million in Q3 2025.
• A 5-year average of $31.1 million and a median of $30.6 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 112.97% in 2022 and slipped 29.18% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $39.0 million in 2022, then declined by 17.93% to $32.0 million in 2023, then fell by 17.17% to $26.5 million in 2024, then fell by 11.36% to $23.5 million in 2025, then decreased by 10.61% to $21.0 million in 2026.
• The last three Research & Development figures came in at $21.0 million (Q2 2026), $23.2 million (Q1 2026), and $23.5 million (Q4 2025), per Business Quant data.